Pre-earnings options volume in Amylyx Pharmaceuticals is normal with puts leading calls 8:3. Implied volatility suggests the market is anticipating a move near 10.6%, or $2.26, after results are released. Median move over the past eight quarters is 5.3%.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AMLX:
- Goldman Sachs Predicts up to 120% Rally for These 2 Stocks — Here’s Why They Have Solid Upside
- Amylyx to host conference call
- Amylyx upgraded to Buy from Neutral at Goldman Sachs
- Amylyx says Government of Quebec to cover ALBRIOZA for ALS
- Amylyx approval still possible despite negative opinion, says Mizuho